MYOKARDIA, INC.

MYOK
End-of-day quote. End-of-day quote  - 11/16
224.91USD +0.05%
Prev.224.8000
Open224.8200
High225.0000
Low224.5200
Volume2 702 319
Latest news
11/18
11/17
11/16
11/16
Chart MYOKARDIA, INC.
Technical analysis trends
Short TermMid-TermLong Term
TrendBullishBullishBullish
Resistance226324295
Spread/Res.-0,54%-31%-24%
Spread/Supp.0,94%65%118%
Support223137103
Financials
Sales 2019 - - -
Net income 2019 -276 M - -
Net cash 2019 416 M - -
P/E ratio 2019 -11,8x
Yield 2019 -
Capitalization 11 993 M 11 993 M -
EV / Sales 2018 49,3x
EV / Sales 2019 -
Nbr of Employees 318
Free-Float 94,3%
Company
MyoKardia, Inc. is a clinical-stage biopharmaceutical company. The Company focuses on the treatment of heritable cardiomyopathies, a group of rare, genetically-driven forms of heart failure that result from biomechanical defects in cardiac muscle contraction. The Company is engaged in the business...

>> Read more
Sector :
Bio Therapeutic Drugs
Calendar :
2021-03-04 Earnings Release
Trading Rating :
Investor Rating : -

Income Statement Evolution
Consensus
Mean consensus -
Number of Analysts
Average target price
Last Close Price 224,91 
Spread / Highest target -
Spread / Average Target -
Spread / Lowest Target -